Further, TRIM-ing of oncogenic proteins HER2 or HER3 alone showed inhibition of their downstream signaling cascade, i.e. ERK activation, and AKT activation, respectively, leading to cell death in HER2-overexpressing overexpression has been reported in breast cancer cells. This evidence concerns the gene AKT1 and breast cancer.